Compare · MDLN vs NMRD
MDLN vs NMRD
Side-by-side comparison of Medline Inc. (MDLN) and Nemaura Medical Inc. (NMRD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NMRD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 527.7x NMRD ($91.1M).
- MDLN has hit the wire 7 times in the past 4 weeks while NMRD has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 2 for NMRD).
- Company
- Medline Inc.
- Nemaura Medical Inc.
- Price
- $35.95-1.74%
- $0.12-5.38%
- Market cap
- $48.08B
- $91.1M
- 1M return
- +11.97%
- -
- 1Y return
- -11.77%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 2
NMRD
Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest NMRD
- Nemaura Medical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEF 14C filed by Nemaura Medical Inc.
- SEC Form NT 10-K filed by Nemaura Medical Inc.
- Nemaura Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Nemaura Medical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form PRE 14C filed by Nemaura Medical Inc.
- CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA
- Nemaura Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Nemaura Medical Inc.
- Nemaura Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits